2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Molecular and biochemical basis <strong>of</strong> disease<br />
mature aging, skin laxity and generalised osteoporosis with spontaneous<br />
fractures . Crani<strong>of</strong>acial dysmorphism include a prominent forehead,<br />
ptosis, large protruding ears, droopy cheeks, flat malar region<br />
and prognathism .<br />
We ascertained a Libanese family in which 3 individuals presented<br />
with GO . The proband aged 1 ½ years is born from sixth-degree consanguineous<br />
parents, while in his 2 maternal uncles (born from a maternal<br />
uncle who married his second-degree cousin) the diagnosis was<br />
posed at 21 and 18 years, respectively . A genome-wide search was<br />
performed by genotyping the 3 affected individuals for microsatellite<br />
markers spaced around 10-15 cM from the ABI PRISM® Linkage Mapping<br />
Set seeking for adjacent homozygous markers . Among 6 positive<br />
regions, haplotype reconstruction and genotyping <strong>of</strong> other family members<br />
allowed the identification <strong>of</strong> a unique informative 47 centimorgan<br />
region <strong>of</strong> homozygosity, shared only by the 3 patients . We generated 9<br />
novel microsatellite markers in order to refine this region and outlined a<br />
locus for GO spanning from 155 .15 to 174 .71 megabases on the long<br />
arm <strong>of</strong> chromosome 1 (max Lod score 3 .2) . Sequencing <strong>of</strong> candidate<br />
genes within the linked interval is still in progress .<br />
P06.118<br />
Large deletions in 9q22.21-9q22.33 region <strong>of</strong> Gorlin syndrome<br />
patients<br />
V. Musani 1 , P. Gorry 2 , A. Basta-Juzbašić 3 , S. Levanat 1 ;<br />
1 Rudjer Boskovic Institute, Zagreb, Croatia, 2 Laboratoire de Génétique, Développement<br />
& Cancer, Université V. Ségalen, Bordeaux, France, 3 Department<br />
<strong>of</strong> Dermatovenerology, University School <strong>of</strong> Medicine, University <strong>of</strong> Zagreb,<br />
Zagreb, Croatia.<br />
Gorlin syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome<br />
(NBCCS) or Basal Cell Nevus Syndrome (BCNS), is an autosomal<br />
dominant disorder that is characterized by various developmental<br />
abnormalities, like cysts <strong>of</strong> the skin, jaw cysts, bone malformations and<br />
different tumors like basal cell carcinomas (BCC) as most frequent,<br />
and also medulloblastomas, meningiomas, fibromas <strong>of</strong> the ovaries and<br />
heart . The prevalence is estimated at one per 57000 . Phenotypical<br />
and genotypical diversity in Gorlin syndrome is referring to inactivating<br />
mutations in only one gene, PTCH, the human homologue <strong>of</strong> the Drosophila<br />
segment-polarity gene patched . PTCH is a tumor suppressor<br />
gene, located at 9q22 .3, encoding a 12-pass transmembrane glycoprotein<br />
that acts as an antagonist in the Hedgehog signaling pathway .<br />
The 34 kb gene contains 23 exons and there are several hundred<br />
mutations, spanning the whole gene . Although there are some recurring<br />
mutations, there are no apparent hot spots . Nonsense, frameshift,<br />
in-frame deletions, splicesite, and missense mutations all have been<br />
described in the Gorlin syndrome patients . In some cases large deletions<br />
in PTCH region have been reported . We developed semi-quantitative<br />
fluorescent multiplex PCR with polymorphic markers surrounding<br />
PTCH and analyzed the whole 9q22 region in 50 Gorlin syndrome<br />
cases from France and Croatia . In three cases we found large deletions<br />
from 4-7 megabases in length, giving some depth and additional<br />
indications for phenotype diversity <strong>of</strong> the Gorlin syndrome .<br />
P06.119<br />
Analysis <strong>of</strong> CTLA Gene Polymorphisms in spanish<br />
Graves`Patients<br />
M. Piñeiro-Gallego 1 , P. Álvarez-Vázquez 2 , L. Constela 3 , R. García -Mayor 2 , D.<br />
Valverde 1 ;<br />
1 Departamento de Bioquímica, Genética e Inmunología., Vigo, Spain, 2 Complejo<br />
Hospitalario Universitario de Vigo., Vigo, Spain, 3 Complejo Hospitalario<br />
Universitario de Vigo, Vigo, Spain.<br />
Graves’ disease (GD) is a common organ-specific autoimmune disease<br />
that affects 0 .5%-1% <strong>of</strong> Western population . It is a multifactorial<br />
disease that develops as the result <strong>of</strong> a complex interaction between<br />
genetic susceptibility genes and environmental factors . GD is characterized<br />
by diffuse goiter, ophthalmopathy, and anti-thyroid-stimulating<br />
hormone receptor antibodies .<br />
Numerous studies have demonstrated the linkage to several polymorphism<br />
<strong>of</strong> the CTLA4 gene . The CTLA4 gene is placed on chromosome<br />
2q33 and codifies the T cell receptor, which negatively modulates the<br />
immune response disabling the T cells . The aim <strong>of</strong> the present work<br />
was to determinate the contribution <strong>of</strong> C/T dimorphism in the promoter<br />
at position -318, the A/G dimorphism at position + 49 in exon 1, and<br />
the C/T60 dimorphism in the 3’UTR <strong>of</strong> the CTLA4 gene to the severity<br />
and manifestations <strong>of</strong> GD .<br />
A cohort <strong>of</strong> 98 patients, and 50 healthy controls were used to genotype<br />
these three SNPs by PCR-RFLPs .<br />
Results from +49A/G showed significant differences for the genotypes<br />
between Graves’ patients and controls . The frequency <strong>of</strong> GG is higher<br />
than in controls, a 6% <strong>of</strong> the controls were homozygous for the G allele,<br />
while for the patients group we found 22%. Furthermore, significant<br />
increase in the frequency <strong>of</strong> the G allele was found in Graves’<br />
patients compared with controls (X²= 6 .04, P=0 .0140)<br />
No statistically significant association has been found with the -318<br />
A/G and CT60 3’UTR polymorphism (X² = 17 .8, P =0 .1815; X² = 0 .79,<br />
P=0 .3729 respectively) .<br />
P06.120<br />
5 base pair deletions in Rab27a gene as hot spot in exon 6 in<br />
Griscelli syndrome (type ii)<br />
S. Shahkarami 1 , Z. Pourpak 2 , M. Houshmand 3 , A. Hamidieh 2 , M. Moin 2 ;<br />
1 Immunology, Asthma and Allergy Institue (IAARI), Tehran, Islamic Republic<br />
<strong>of</strong> Iran, 2 Immunology, Asthma and Allergy Institue (IAARI),, Tehran, Islamic<br />
Republic <strong>of</strong> Iran, 3 National Institute <strong>of</strong> Genetic Engineering and Biotechnology,<br />
and Medical Genetic Lab, Special Medical Center, Tehran, Iran, Tehran, Islamic<br />
Republic <strong>of</strong> Iran.<br />
Griscelli syndrome (GS), an autosomal recessive disorder, is characterized<br />
by a silver-gray sheen <strong>of</strong> the hair and the presence <strong>of</strong> large<br />
clusters <strong>of</strong> pigment in the hair shaft . GS can be associated to neurological<br />
impairment (GS1), immunodeficiency (GS2), or be isolated<br />
(GS3) .<br />
GS2 is caused by a mutation in the small GTPase RAB A gene . The<br />
aim <strong>of</strong> this study was to investigate mutations in RAB A gene, in a<br />
3 year-old boy who was referred to our center with immunodeficiency<br />
and silver gray sheen <strong>of</strong> the hair .<br />
Material and method: Genomic DNA was extracted from peripheral<br />
blood cells by salting out method. Five coding exons were amplified by<br />
PCR-Sequencing methods and sequenced to detect probable mutations<br />
in RAB A gene .<br />
Result: A homozygote deletion was found in exon 6 <strong>of</strong> the RAB A<br />
gene .<br />
Discussion: This deletion leads to a frame shift mutation in exon 6 and<br />
a premature stop codon. Clinical manifestations and immunodeficiency<br />
help physician to suspect diagnosis <strong>of</strong> GS II . As molecular analysis<br />
has provided an exact way to investigate mutations in immunodeficient<br />
patients like GS, it can be considered as a very useful method for<br />
definite diagnosis.<br />
Because <strong>of</strong> an amino acid deletion and frame shift in this exon, we<br />
conclude that this new deletion is pathogen . Other deletions were<br />
found and reported in the same exon as causative mutation . We believe<br />
that this region may be a hot spot for GS II and suggest that the<br />
first analysis for other patients must be done in this region.<br />
P06.121<br />
Association study <strong>of</strong> the glycogen synthase kinase-3 beta<br />
(GSK3beta) gene with Mood Disorders<br />
M. Gratacòs 1 , V. Soria 2 , E. Saus 1 , F. Vivarelli 1 , J. R. González 3 , J. Valero 4 , È.<br />
Martínez-Amorós 2 , M. Bayés 1 , A. Gutiérrez-Zotes 4 , J. M. Crespo 2,5 , L. Martorell 4 ,<br />
E. Vilella 4 , A. Labad 4 , J. M. Menchón 2,5 , J. Vallejo 2,5 , X. Estivill 1,6 , M. Urretavizcaya<br />
2,5 ;<br />
1 CIBERESP (CIBER en Epidemiología y Salud Pública), Genes and Disease<br />
Program and CeGen <strong>Barcelona</strong> Genotyping Node, Center for Genomic Regulation,<br />
<strong>Barcelona</strong>, Catalonia, Spain, 2 Mood Disorders Clinical and Research Unit,<br />
CIBER-SAM, Psychiatry Department, Bellvitge University Hospital, L’Hospitalet<br />
de Llobregat, <strong>Barcelona</strong>, Catalonia, Spain, 3 CREAL, Center for Research in<br />
Environmental Epidemiology, <strong>Barcelona</strong>, Catalonia, Spain, 4 Grup d’Investigació<br />
en Psiquiatria. Hospital Universitari Institut Pere Mata, Rovira i Virgili University,<br />
Reus, Tarragona, Catalonia, Spain, 5 Department <strong>of</strong> Clinical Sciences, Bellvitge<br />
Campus, <strong>Barcelona</strong> University, <strong>Barcelona</strong>, Catalonia, Spain, 6 Experimental and<br />
Health Sciences Department, Pompeu Fabra University, <strong>Barcelona</strong>, Catalonia,<br />
Spain.<br />
Glycogen synthase kinase-3beta (GSK3beta) is a key component <strong>of</strong><br />
the Wnt signaling pathway and is known to regulate such critical cellular<br />
functions as structure, gene expression, mobility and apoptosis .<br />
Recent findings support that GSK3beta may play a role in the pathophysiology<br />
and treatment <strong>of</strong> Mood Disorders (MD) . We hypothesize<br />
that genetic variants, including SNPs and CNVs (Copy Number Varia-